Anti-Adenovirus hexon protein antibody [1E11] (ab8251)

Publishing research using ab8251? Please let us know so that we can cite the reference in this datasheet.

ab8251 has been referenced in 5 publications.

  • Hassan F  et al. Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability. Mol Ther Oncolytics 8:52-61 (2018). PubMed: 29511732
  • Garcia-Carbonero R  et al. Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. J Immunother Cancer 5:71 (2017). IHC-P . PubMed: 28923104
  • Pang T  et al. Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma. Oncotarget 8:76468-76478 (2017). PubMed: 29100326
  • Yilmazer A  et al. Development of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers. PLoS One 9:e114985 (2014). PubMed: 25501573
  • Van den Bossche J  et al. Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. Biomaterials 32:3085-93 (2011). Dot blot . PubMed: 21269689

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up